MRNA
MRNA
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
1
$11.69M
Total Volume
$11.69M
1 transactions
Net Activity
$11.69M
Net selling
Sentiment Rating
Moderate DistributionCEO Conviction Index
No Recent Signal
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
MRNA has an insider buy conviction of 0%, compared to the Unknown sector buy average of 50%.
Hoge Stephen
Pres
$11.69M total
Over the last 90 days, corporate insiders at MRNA (MRNA) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 1 were sales. The total volume of insider trading reached $11.69M.
The net insider activity for MRNA shows a net selling bias of $11.69M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Hoge Stephen (Pres), who traded 80.6K shares valued at $11.69M on Sep 14, 2026.
Quick Actions
FAQs About MRNA Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for MRNA.